These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 38418571)

  • 41. Isatoic anhydrides as novel inhibitors of monoamine oxidase.
    Hitge R; Petzer A; Petzer JP
    Bioorg Med Chem; 2022 Nov; 73():117030. PubMed ID: 36179486
    [TBL] [Abstract][Full Text] [Related]  

  • 42. QSAR and molecular docking techniques for the discovery of potent monoamine oxidase B inhibitors: computer-aided generation of new rasagiline bioisosteres.
    Speck-Planche A; Kleandrova VV
    Curr Top Med Chem; 2012; 12(16):1734-47. PubMed ID: 23030609
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Development of Halogenated Pyrazolines as Selective Monoamine Oxidase-B Inhibitors: Deciphering via Molecular Dynamics Approach.
    Nair AS; Oh JM; Koyiparambath VP; Kumar S; Sudevan ST; Soremekun O; Soliman ME; Khames A; Abdelgawad MA; Pappachen LK; Mathew B; Kim H
    Molecules; 2021 May; 26(11):. PubMed ID: 34071665
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Exploration of a new class of monoamine oxidase B inhibitors by assembling benzyloxy pharmacophore on halogenated chalcones.
    Singh AK; Kim SM; Oh JM; Abdelgawad MA; Ghoneim MM; Rangarajan TM; Kumar S; Sudevan ST; Trisciuzzi D; Nicolotti O; Kim H; Mathew B
    Chem Biol Drug Des; 2023 Aug; 102(2):271-284. PubMed ID: 37011915
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Discovery, biological evaluation, and structure-activity and -selectivity relationships of 6'-substituted (E)-2-(benzofuran-3(2H)-ylidene)-N-methylacetamides, a novel class of potent and selective monoamine oxidase inhibitors.
    Pisani L; Barletta M; Soto-Otero R; Nicolotti O; Mendez-Alvarez E; Catto M; Introcaso A; Stefanachi A; Cellamare S; Altomare C; Carotti A
    J Med Chem; 2013 Mar; 56(6):2651-64. PubMed ID: 23437843
    [TBL] [Abstract][Full Text] [Related]  

  • 46. (Hetero-)(arylidene)arylhydrazides as Multitarget-Directed Monoamine Oxidase Inhibitors.
    Palakkathondi A; Oh JM; Dev S; Rangarajan TM; Kaipakasseri S; Kavully FS; Gambacorta N; Nicolotti O; Kim H; Mathew B
    ACS Comb Sci; 2020 Nov; 22(11):592-599. PubMed ID: 33047950
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Identification of Butyrylcholinesterase and Monoamine Oxidase B Targeted Ligands and their Putative Application in Alzheimer's Treatment: A Computational Strategy.
    Jabir NR; Rehman MT; Tabrez S; Alserihi RF; AlAjmi MF; Khan MS; Husain FM; Ahmed BA
    Curr Pharm Des; 2021; 27(20):2425-2434. PubMed ID: 33634754
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Design, synthesis, in-vitro, in-vivo and ex-vivo pharmacology of thiazolidine-2,4-dione derivatives as selective and reversible monoamine oxidase-B inhibitors.
    Jadoon R; Aamir Javed M; Saeed Jan M; Ikram M; Mahnashi MH; Sadiq A; Shahid M; Rashid U
    Bioorg Med Chem Lett; 2022 Nov; 76():128994. PubMed ID: 36162779
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Monoamine Oxidase Inhibitors: From Classic to New Clinical Approaches.
    Duarte P; Cuadrado A; León R
    Handb Exp Pharmacol; 2021; 264():229-259. PubMed ID: 32852645
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identification of novel monoamine oxidase selective inhibitors employing a hierarchical ligand-based virtual screening strategy.
    Wang D; Li Z; Liu Y; Chen M; Chen N; Zuo Z; Kong DX
    Future Med Chem; 2019 Apr; 11(8):801-816. PubMed ID: 31140884
    [No Abstract]   [Full Text] [Related]  

  • 51. 3D-QSAR and in-silico Studies of Natural Products and Related Derivatives as Monoamine Oxidase Inhibitors.
    Dhiman P; Malik N; Khatkar A
    Curr Neuropharmacol; 2018; 16(6):881-900. PubMed ID: 29189167
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Selective MAO-B inhibitors: a lesson from natural products.
    Carradori S; D'Ascenzio M; Chimenti P; Secci D; Bolasco A
    Mol Divers; 2014 Feb; 18(1):219-43. PubMed ID: 24218136
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Discovery of 3-Hydroxy-3-phenacyloxindole Analogues of Isatin as Potential Monoamine Oxidase Inhibitors.
    Tripathi RK; Krishnamurthy S; Ayyannan SR
    ChemMedChem; 2016 Jan; 11(1):119-32. PubMed ID: 26592797
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Field and atom-based 3D-QSAR models of chromone (1-benzopyran-4-one) derivatives as MAO inhibitors.
    Saha M; Gupta S; Dhiman S; Asati V; Ali A; Ali A
    J Biomol Struct Dyn; 2023; 41(21):12171-12185. PubMed ID: 36650997
    [TBL] [Abstract][Full Text] [Related]  

  • 55. 2-Heteroarylidene-1-indanone derivatives as inhibitors of monoamine oxidase.
    Nel MS; Petzer A; Petzer JP; Legoabe LJ
    Bioorg Chem; 2016 Dec; 69():20-28. PubMed ID: 27662218
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Monoamine oxidase (MAO) inhibitory activity: 3-phenylcoumarins versus 4-hydroxy-3-phenylcoumarins.
    Delogu GL; Serra S; Quezada E; Uriarte E; Vilar S; Tatonetti NP; Viña D
    ChemMedChem; 2014 Aug; 9(8):1672-6. PubMed ID: 24782464
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Extended Double Bond Conjugation in the Chalcone Framework Favours MAO-B Inhibition: A Structural Perspective on Molecular Dynamics.
    Agoni C; Issahaku AR; Abdelgawad MA; Khames A; Soliman MES; Mathew B
    Comb Chem High Throughput Screen; 2022; 25(12):2059-2069. PubMed ID: 35156567
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Monoamine oxidase B inhibitors based on natural privileged scaffolds: A review of systematically structural modification.
    Lv Y; Zheng Z; Liu R; Guo J; Zhang C; Xie Y
    Int J Biol Macromol; 2023 Nov; 251():126158. PubMed ID: 37549764
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Structure-based design and analysis of MAO-B inhibitors for Parkinson's disease: using in silico approaches.
    Kare P; Bhat J; Sobhia ME
    Mol Divers; 2013 Feb; 17(1):111-22. PubMed ID: 23325357
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In silico design of novel 2H-chromen-2-one derivatives as potent and selective MAO-B inhibitors.
    Pisani L; Farina R; Nicolotti O; Gadaleta D; Soto-Otero R; Catto M; Di Braccio M; Mendez-Alvarez E; Carotti A
    Eur J Med Chem; 2015 Jan; 89():98-105. PubMed ID: 25462230
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.